Kris O'Brien | Director, Operational Strategy
ERGOMED

Kris O'Brien, Director, Operational Strategy, ERGOMED

Kris O'Brien has nearly four decades of experience in the clinical research industry, spanning roles in contract research organizations (CROs), pharmaceutical companies, and academia. Throughout her career, she has worked across a wide range of therapeutic areas, with a strong focus on rare diseases.
As a subject matter expert in rare disease research, Kris has spent significant time collaborating with patient advocacy organizations and patient-led support groups to ensure that the voices of those living with rare conditions are meaningfully represented in every study opportunity. She integrates patient feedback into strategic study insights, driving successful enrollment and retention.
With a long and successful background in clinical operations, Kris brings a comprehensive understanding of all aspects of study execution. She combines this operational expertise with a deep passion for patient-centric research, ensuring success from study inception through completion.

Appearances:



Day 1 - World Orphan Drug Congress USA 2026 @ 14:50

Inside the Policy Process: How Advocates Can Engage Decision-Makers for Greater Impact

Session led by: ERGOMED
last published: 01/Apr/26 15:35 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 

 

To Sponsor Or Exhibit

 
 

Jack Rendell
jack.rendell@terrapinn.com
t/ +44 07577689029

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Jasper Cameron
jasper.cameron@terrapinn.com